Table 2.
Characteristic | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
|
|
|||||
HR | 95% CI | P | HR | 95% CI | P | |
Transcriptomic risk | ||||||
Low | Ref | Ref | Ref | Ref | Ref | Ref |
Intermediate | 4.94 | 1.16 to 21.1 | 0.03 | 4.75 | 1.07 to 21.1 | 0.04 |
High | 43.7 | 10.2 to 186 | < 0.001 | 44.8 | 8.62 to 233 | < 0.001 |
Stage | ||||||
I | Ref | Ref | Ref | Ref | Ref | Ref |
II | 0.66 | 0.28 to 1.52 | 0.33 | 0.36 | 0.0841 to 1.56 | 0.17 |
III | 1.23 | 0.58 to 2.63 | 0.59 | 0.42 | 0.0547 to 3.27 | 0.41 |
IV | 6.22 | 2.89 to 13.4 | < 0.001 | 28.1 | 3.73 to 212 | 0.001 |
Grade | ||||||
1 | Ref | Ref | Ref | |||
2 | 1.06 | 0.25 to 4.47 | 0.94 | Not included | ||
3 | 1.01 | 0.23 to 4.34 | 0.99 | |||
Lymph Node Status | ||||||
Negative | Ref | Ref | Ref | Ref | Ref | Ref |
Positive | 2.16 | 1.03 to 4.55 | 0.043 | 2.92 | 1.32 to 6.44 | 0.008 |